UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 146

Sortiert nach

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial

Diabetes, obesity & metabolism, 2009-06, Vol.11 (6), p.611-622

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of birinapant in combination with carboplatin in targeting platinum‑resistant epithelial ovarian cancers

International journal of oncology, 2022-03, Vol.60 (3), p.1, Article 35

2022

Link zum Volltext

Verfügbarkeit prüfen

Durability of glycaemic control with dapagliflozin, an SGLT2 inhibitor, compared with saxagliptin, a DPP4 inhibitor, in patients with inadequately controlled type 2 diabetes

Diabetes, obesity & metabolism, 2019-11, Vol.21 (11), p.2564-2569

2019

Link zum Volltext

Verfügbarkeit prüfen

Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer

Current opinion in urology, 2020-01, Vol.30 (1), p.98

2020

Link zum Volltext

Verfügbarkeit prüfen

Dipeptidyl peptidase-4 inhibitors: pharmacokinetics, efficacy, tolerability and safety in renal impairment

Diabetes, obesity & metabolism, 2014-10, Vol.16 (10), p.891-899

Davis, T. M. E.

2014

Link zum Volltext

Verfügbarkeit prüfen

Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin

Archives of Endocrinology and Metabolism, 2018-08, Vol.62 (4), p.424-430

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of VX‑765 on the transcriptome profile of mice spinal cords with acute injury

Molecular medicine reports, 2020-07, Vol.22 (1), p.33-42

2020

Link zum Volltext

Verfügbarkeit prüfen

The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma

Oncotarget, 2016-10, Vol.7 (43), p.69625-69637

2016

Link zum Volltext

Verfügbarkeit prüfen

Baseline differences in the SAVOR trial

Diabetes, obesity & metabolism, 2015-12, Vol.17 (12), p.1202-1202

2015

Link zum Volltext

Verfügbarkeit prüfen

Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis

Diabetes, obesity & metabolism, 2012-06, Vol.14 (6), p.481-492

2012

Link zum Volltext

Verfügbarkeit prüfen

Saxagliptin and Heart Failure in the SAVOR-TIMI 53 Trial: Reflections on the Bradford Hill Criteria

Revista española de cardiología (English ed.), 2017-12, Vol.70 (12), p.1143-1144

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of L-ornithine L-aspartate granules in treating chronic liver disease in patients with high-level serum gamma-glutamyltransferase

Zhonghua gan zang bing za zhi, 2014-07, Vol.22 (7), p.525

2014

Link zum Volltext

Verfügbarkeit prüfen

Aspartate-ornithine granules in the treatment of nonalcoholic steatohepatitis: a multiple-dose parallel controlled clinical trial

Zhonghua gan zang bing za zhi, 2013-07, Vol.21 (7), p.528

2013

Link zum Volltext

Verfügbarkeit prüfen

Saxagliptin efficacy

Diabetes, obesity & metabolism, 2010-08, Vol.12 (8), p.734-734

Valiquette, G.

2010

Link zum Volltext

Verfügbarkeit prüfen

Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

IDrugs : the investigational drugs journal, 2008-12, Vol.11 (12), p.906

Gallwitz, Baptist

2008

Link zum Volltext

Verfügbarkeit prüfen

Ornithine aspartate and naloxone combined therapy for hepatic encephalopathy affects cognitive function, prognosis, and neuropeptide levels

Zhonghua gan zang bing za zhi, 2013-05, Vol.21 (5), p.385

2013

Link zum Volltext

Verfügbarkeit prüfen

Alanyl-glutamine dipeptide inhibits hepatic ischemia-reperfusion injury in rats

World journal of gastroenterology : WJG, 2006-03, Vol.12 (9), p.1373

2006

Link zum Volltext

Verfügbarkeit prüfen

Study on L-Ornithine-L-Aspartate in the treatment of acute-on-chronic liver failure

Zhonghua gan zang bing za zhi, 2011-01, Vol.19 (1), p.63

2011

Link zum Volltext

Verfügbarkeit prüfen

Role of cathepsin B-mediated apoptosis in fulminant hepatic failure in mice

World journal of gastroenterology : WJG, 2009-03, Vol.15 (10), p.1231-1236

2009

Link zum Volltext

Verfügbarkeit prüfen

Treatment of multiresistant Acinetobacter baumannii infections

Current opinion in investigational drugs (London, England : 2000), 2009-02, Vol.10 (2), p.150

2009

Link zum Volltext

Verfügbarkeit prüfen

Confocal Raman Spectral Imaging Study of DAPT, a γ-secretase Inhibitor, Induced Physiological and Biochemical Reponses in Osteosarcoma Cells

International journal of medical sciences, 2020-01, Vol.17 (5), p.577-590

2020

Link zum Volltext

Verfügbarkeit prüfen

Effects of matrix metalloproteinases inhibitor GM6001 on choroidal neovascularization

Chung-hua yen k'o tsa chih, 2012-08, Vol.48 (8), p.744

2012

Link zum Volltext

Verfügbarkeit prüfen

No heart risk--or benefit--from diabetes drug Onglyza

Harvard heart letter, 2013-12, Vol.24 (4), p.8

2013

Link zum Volltext

Verfügbarkeit prüfen

PSMA-targeted radioligand therapy in prostate cancer

Urologe. Ausgabe A, 2017-01, Vol.56 (1), p.32

2017

Link zum Volltext

Verfügbarkeit prüfen

A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis

Chemistry & biology, 2012-09, Vol.19 (9), p.1142-1151

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 146

Suche als RSS-Feed

Aktive Filter

KollektionSage Journals

Nur zeigenGeprüft (Peer-Review)

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(42)

Publikationsform

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Dipeptides - Therapeutic Use
(117)
Humans
(103)
Science & Technology
(61)
Life Sciences & Biomedicine
(59)
Male
(58)
Animals
(57)
Dipeptides - Pharmacology
(38)
Female
(38)
Middle Aged
(27)
Adult
(26)
Rats
(23)
Adamantane - Analogs & Derivatives
(22)
Diabetes Mellitus, Type 2 - Drug Therapy
(22)
Dipeptides - Administration & Dosage
(21)
Treatment Outcome
(21)
Mice
(20)
Pharmacology & Pharmacy
(18)
Adamantane - Therapeutic Use
(17)
Dipeptidyl-Peptidase Iv Inhibitors - Therapeutic Use
(17)
Dipeptides - Adverse Effects
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial

Efficacy of birinapant in combination with carboplatin in targeting platinum‑resistant epithelial ovarian cancers

Durability of glycaemic control with dapagliflozin, an SGLT2 inhibitor, compared with saxagliptin, a DPP4 inhibitor, in patients with inadequately controlled type 2 diabetes

Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer

Dipeptidyl peptidase-4 inhibitors: pharmacokinetics, efficacy, tolerability and safety in renal impairment

Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin

Effect of VX‑765 on the transcriptome profile of mice spinal cords with acute injury

The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma

Baseline differences in the SAVOR trial

Saxagliptin and sitagliptin in adult patients with type 2 diabetes: a systematic review and meta-analysis

Saxagliptin and Heart Failure in the SAVOR-TIMI 53 Trial: Reflections on the Bradford Hill Criteria

Effect of L-ornithine L-aspartate granules in treating chronic liver disease in patients with high-level serum gamma-glutamyltransferase

Aspartate-ornithine granules in the treatment of nonalcoholic steatohepatitis: a multiple-dose parallel controlled clinical trial

Saxagliptin efficacy

Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

Ornithine aspartate and naloxone combined therapy for hepatic encephalopathy affects cognitive function, prognosis, and neuropeptide levels

Alanyl-glutamine dipeptide inhibits hepatic ischemia-reperfusion injury in rats

Study on L-Ornithine-L-Aspartate in the treatment of acute-on-chronic liver failure

Role of cathepsin B-mediated apoptosis in fulminant hepatic failure in mice

Treatment of multiresistant Acinetobacter baumannii infections

Confocal Raman Spectral Imaging Study of DAPT, a γ-secretase Inhibitor, Induced Physiological and Biochemical Reponses in Osteosarcoma Cells

Effects of matrix metalloproteinases inhibitor GM6001 on choroidal neovascularization

No heart risk--or benefit--from diabetes drug Onglyza

PSMA-targeted radioligand therapy in prostate cancer

A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis

Aktive Filter

Suchergebnisse filtern